Research Article

Analgesic Efficacy of Intravenous Ibuprofen in the Treatment of Postoperative Acute Pain: A Phase III Multicenter Randomized Placebo-ControlledDouble-Blind Clinical Trial

Table 1

Demographic profiles and other information about patients.

CharacteristicsPlacebo group (n = 119)IVIB 400 mg group (n = 115)IVIB 800 mg group (n = 111)

Age (y); M ± StD52.89 ± 10.6652.79 ± 12.4552.95 ± 11.13
Gender; n (%)
 Male62 (52.10)63 (54.78)67 (60.36)
 Female57 (47.90)52 (45.22)44 (39.64)
Ethnicity; n (%)
 Han117 (98.32)114 (99.13)109 (98.20)
 Other2 (1.68)1 (0.87)2 (1.80)
Height (cm); M ± StD164.26 ± 7.65164.26 ± 7.93164.77 ± 8.26
Weight (Kg); M ± StD62.54 ± 11.1861.90 ± 11.6061.50 ± 10.35
BMI (Kg/m2); M ± StD23.10 ± 3.2922.82 ± 3.1822.56 ± 2.77
Smoking history; n (%)
 No97 (81.51)88 (76.52)84 (75.68)
 Yes22 (18.49)27 (23.48)27 (24.32)
History of alcohol consumption; n (%)
 Never96 (80.67)85 (73.91)93 (83.78)
 Occasionally11 (9.24)17 (14.78)5 (4.50)
 Frequently12 (10.08)13 (11.30)13 (11.71)
History of drug dependence; n (%)
 No117 (98.32)115 (100.00)111 (100.00)
 Yes2 (1.68)0 (0.00)0 (0.00)
History of drug allergy; n (%)
 No110 (92.44)106 (92.17)109 (98.20)
 Yes9 (7.56)9 (7.83)2 (1.80)
Previous surgical history; n (%)
 No105 (88.24)100 (86.96)94 (84.68)
 Yes14 (11.76)15 (13.04)17 (15.32)
Another previous medical history within the past 1 y; n (%)
 No59 (49.58)60 (52.17)61 (54.95)
 Yes60 (50.42)55 (47.83)50 (45.05)
Type of surgery; n (%)
 Abdominal surgery58 (48.74)60 (52.17)56 (50.45)
 Orthopaedic surgery61 (51.26)55 (47.83)55 (49.55)
Classification of ASA; n (%)
 I31 (26.05)25 (21.74)27 (24.32)
 II86 (72.27)88 (76.52)84 (75.68)
 III2 (1.68)2 (1.74)0 (0.00)
Duration of surgery (min); M ± StD206.19 ± 95.93215.61 ± 88.97205.50 ± 98.09
Whether to use prophylactic antiemetic drugs; n (%)
 No25 (21.01)27 (23.48)28 (25.23)
 Yes94 (78.99)88 (76.52)83 (74.77)

y: years, cm: centimeter, Kg: kilogram, min: minutes, ASA: American Society of Anesthesiologists. M ± StD: means ± standard deviation.